J.E. Mcdonough

Nabriva Therapeutics (Austria) — Austria

Medicine · Health Sciences

3h-index18citations37works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(14), Chronic Obstructive Pulmonary Disease (COPD) Research(7), Neonatal Respiratory Health Research(7), Cancer-related molecular mechanisms research(3), Single-cell and spatial transcriptomics(3)

Publications37 total

Integration of Multiomic and Multi-phenotypic Data Identifies Biological Pathways Associated with Physical Fitness
2025Open Access
The Potential Role of GPR87 in the Development of Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025
Abstract 3467: Delivery of CpG and GM-CSF in a novel silica-based scaffold leads to differentiation of AML blasts and T cell-dependent immunity in syngeneic AML tumor models
Cancer Research·2025
Centanafadine Sustained Release Is Efficacious in the Treatment of Adult ADHD Across Disease Severities
CNS Spectrums·2024Open Access
Spatial Transcriptomic Analysis Allow the Identification of Abnormal Airway Niches in the Fibrotic Lung
2023
The Pulmonary Fibrosis Drug Connectome
2023
Online Cell Atlases Improve Interrogation of Lung Transcriptomic Data
2023
Aberrant Basaloid Cells and Closely Connected Intermediate State Cells Are Involved in the Injury Repair Process of the Fibrotic Lungs in the Aftermath of Severe COVID-19
2023
Morphometrics and Mucosal Immune Features in Lungs With End-stage Chronic Obstructive Pulmonary Disease
2023
Cellular Ageing and Senescence Transcriptional Modules in the Aged Human Lung
2023
JAK-STAT pathway is upregulated in CLAD
2022
Decellularized Lung Tissue Proteomics Showed Decreased Surfactant and Increased Inflammatory Proteins in the Aged Lung
2022
A Probabilistic Graphical Model for Understanding Cellular Dynamics in Idiopathic Pulmonary Fibrosis Progression
2022
Live Imaging the Dynamic Spatiotemporal Behavior of Alveolar Type 2 Cells in Response to Bleomycin Induced Lung Injury
2022
Reduced Alveolar Type 2 Epithelial Expression of NUPR1 Is Associated with Severe COPD and Increases Susceptibility to Oxidative Stress and Ferroptosis
2022
Aberrant Mesenchymal Signaling in the COPD Lung
2022
Leveraging Cell-Specific Disease Signatures to Predict New Drug Therapies for Idiopathic Pulmonary Fibrosis
2022
Interactive Web-Based Lung Cell Atlases Lower Barriers to Transcriptomic Data Sharing, Mining and Dissemination
2022
New Insights on Idiopathic Pulmonary Fibrosis Revealed by Proteomics and Lipidomics Analysis of Human Tissue Cores
2022
Single Nuclei RNA Sequencing of Differentially Affected Regions in IPF Lungs Suggests a Central Role of Aberrant Basaloid Cells in Disease Progression
2022
page 1 of 2Next →

Frequent Co-authors

Naftali Kaminski(25), Jonas C. Schupp(21), Carlos Cosme(9), Farida Ahangari(9), Giuseppe DeIuliis(9), Xiting Yan(9), Bart Vanaudenaerde(9), Maor Sauler(8), Jonathan D. Cooper(6), Taylor Adams(6), A. Justet(6), Thomas G. Adams(6), Maurizio Chioccioli(5), Norihito Omote(5), JC Hogg(5), Yan Xia(5), Laurens De Sadeleer(5), Jane Flint(5), Neeharika Kothapalli(4), Sergio Poli(4)